BCWORLD PHARM. Co., Ltd. (200780.KQ)

KRW 4810.0

(0.73%)

Operating Income Summary of BCWORLD PHARM. Co., Ltd.

BCWORLD PHARM. Co., Ltd.'s latest annual operating income in 2023 was 6.36 Billion KRW , up 241.91% from previous year.
BCWORLD PHARM. Co., Ltd.'s latest quarterly operating income in 2024 Q2 was -316.33 Million KRW , up 178.8% from previous quarter.
BCWORLD PHARM. Co., Ltd. reported an annual operating income of 1.86 Billion KRW in 2022, up 221.39% from previous year.
BCWORLD PHARM. Co., Ltd. reported an annual operating income of -1.53 Billion KRW in 2021, down -6.43% from previous year.
BCWORLD PHARM. Co., Ltd. reported a quarterly operating income of -316.33 Million KRW for 2024 Q2, up 178.8% from previous quarter.
BCWORLD PHARM. Co., Ltd. reported a quarterly operating income of 1.62 Billion KRW for 2023 Q1, down -0.56% from previous quarter.

Annual Operating Income Chart of BCWORLD PHARM. Co., Ltd. (2023 - 2015)

Historical Annual Operating Income of BCWORLD PHARM. Co., Ltd. (2023 - 2015)

Year	Operating Income	Operating Income Growth
2023	6.36 Billion KRW	241.91%
2022	1.86 Billion KRW	221.39%
2021	-1.53 Billion KRW	-6.43%
2020	-1.44 Billion KRW	-43.43%
2019	-1 Billion KRW	-117.94%
2018	5.6 Billion KRW	-36.89%
2017	8.87 Billion KRW	28.41%
2016	6.91 Billion KRW	4.46%
2015	6.61 Billion KRW	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	-482.26 Million KRW	-153.73%
2024 Q2	-316.33 Million KRW	178.8%
2023 Q1	1.62 Billion KRW	-0.56%
2023 Q2	3.06 Billion KRW	88.81%
2023 Q3	781.25 Million KRW	-74.5%
2023 Q4	897.61 Million KRW	14.89%
2023 FY	6.36 Billion KRW	241.91%
2022 Q2	-148.29 Million KRW	-113.96%
2022 FY	1.86 Billion KRW	221.39%
2022 Q4	1.63 Billion KRW	338.4%
2022 Q3	-684.49 Million KRW	-361.58%
2022 Q1	1.06 Billion KRW	121.25%
2021 Q1	720.76 Million KRW	112.6%
2021 FY	-1.53 Billion KRW	-6.43%
2021 Q4	-5 Billion KRW	-456.39%
2021 Q3	1.4 Billion KRW	33.2%
2021 Q2	1.05 Billion KRW	46.17%
2020 Q1	797.52 Million KRW	113.17%
2020 Q2	1.23 Billion KRW	55.28%
2020 FY	-1.44 Billion KRW	-43.43%
2020 Q4	-5.71 Billion KRW	-460.51%
2020 Q3	1.58 Billion KRW	28.09%
2019 Q4	-6.05 Billion KRW	-507.63%
2019 Q3	1.48 Billion KRW	-20.49%
2019 Q2	1.86 Billion KRW	10.08%
2019 Q1	1.69 Billion KRW	210.71%
2019 FY	-1 Billion KRW	-117.94%
2018 FY	5.6 Billion KRW	-36.89%
2018 Q4	-1.53 Billion KRW	-162.34%
2018 Q3	2.45 Billion KRW	0.06%
2018 Q2	2.45 Billion KRW	10.92%
2018 Q1	2.21 Billion KRW	-5.08%
2017 Q1	2.07 Billion KRW	0.0%
2017 FY	8.87 Billion KRW	28.41%
2017 Q3	2.3 Billion KRW	6.99%
2017 Q2	2.15 Billion KRW	3.8%
2017 Q4	2.33 Billion KRW	1.23%
2016 FY	6.91 Billion KRW	4.46%
2015 FY	6.61 Billion KRW	0.0%

Peer Operating Income Comparison of BCWORLD PHARM. Co., Ltd.

Name	Operating Income	Operating Income Difference
Oscotec Inc.	-30.62 Billion KRW	120.781%